Position in VKTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$135,990,416
+$37,917,203 QoQ
Shares Held
3,486,040
+15.7% QoQ
Ownership
2.99%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#7
of 435 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 43%
Shared 0%
None 57%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. VKTX ranks #23 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in VKTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $135,990,416 | 3,486,040 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $98,073,213 | 3,013,928 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $108,223,176 | 3,076,270 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $98,001,193 | 3,729,117 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $86,063,889 | 3,247,694 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $75,363,838 | 3,120,656 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $104,367,063 | 2,593,615 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $118,696,432 | 1,874,845 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $50,211,439 | 947,207 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $81,948,422 | 999,371 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $28,159,363 | 1,513,131 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $9,859,847 | 890,682 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $21,413,033 | 1,320,977 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $14,628,871 | 878,611 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,459,169 | 580,763 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,085,933 | 399,241 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,910,772 | 661,168 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $1,069,512 | 356,504 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $1,033,356 | 224,643 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,618,598 | 257,739 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,687,058 | 448,591 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $769,353 | 121,637 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $484,624 | 86,079 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,994,652 | 342,724 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,221,401 | 169,404 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $373,852 | 79,883 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||